--Activist hedge fund Bluebell Capital Partners has taken a small stake in GlaxoSmithKline PLC to push for Chief Executive Emma Walmsley to reapply for her job, the Financial Times reports.

--Bluebell said the pharma company should launch a "thorough and robust process" to find a leader as Ms. Walmsley's time as CEO has resulted in lower shareholder returns than those of rivals, according to the FT.

Full story: https://on.ft.com/3kwC1sP

Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com

(END) Dow Jones Newswires

09-23-21 0616ET